Better post-approval monitoring of devices advocated in the US
This article was originally published in RAJ Devices
Executive Summary
A more rigorous device approval process in the US may well remedy some of the concerns surrounding medical devices that have been aired by Congress, but emphasis should also be placed on post-approval monitoring, Stanford Health Policy Director Alan Garber, writing in the New England Journal of Medicine on 24 March, argues1.
You may also be interested in...
US: The sun shines in on industry-doctor relationships
The US healthcare reform proposals signed into law on 23 March include requirements on medical device companies to reveal payments or gifts they make to doctors. Peter Rixon takes a closer look at what the reforms’ “sunshine” provisions actually mean
Global regulators/industry to gather in US and Germany to talk device regulation
Compliance, approvals, inspections and many other burning issues will be on the agenda of a US conference that takes place in the coming weeks.
Global regulators and industry execs to gather in US and Germany to talk device regulation
Compliance, approvals, inspections and many other burning issues will be on the agenda of a US conference that takes place in early May.